The chief executive of the company behind Ozempic and Wegovy blamed insurers and middlemen for the high costs of weight-loss ...

A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...

WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo ...

U.S. Senator Bernie Sanders announced commitments from all major pharmacy benefit managers (PBMs) to expand coverage of Novo Nordisk's diabetes and weight-loss drugs, Ozempic and Wegovy, if the ...

Novo Nordisk's CEO, Lars Fruergaard Jørgensen, faced tough questions on Capitol Hill Tuesday as lawmakers pressed the company ...

Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, is set to grill Novo ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs ...

Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...

U.S. Senator Bernie Sanders plans to question Novo Nordisk CEO Lars Jorgensen about the high prices of their weight-loss and ...

The net prices of Ozempic and Wegovy, or the amount that Novo Nordisk is actually paid for the drugs, have dropped substantially since their launch and are expected to fall even further, the company's ...

Sen. Bernie Sanders (I-VT) is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its popular weight-loss and diabetes medicines that can cost Americans more ...